Josef Kroupa: Landmark PRAGUE-26 Trial Advances Interventional PE Treatment
Josef Kroupa, Interventional Cardiologist, Healthcare Consultant, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in The New England Journal of Medicine, adding:
“Czech cardiology at the forefront.
Today, at the Congress of the European Society of Cardiology, we presented to the international cardiovascular community the results of the largest randomized trial to date investigating interventional treatment of acute pulmonary embolism (PRAGUE-26).
At the same time, its results are being published in The New England Journal of Medicine (NEJM) — marking the first original Czech study in history to be published in the journal.
Behind this study are years of hard work, an extraordinary team effort, and above all, a shared ambition to change the way this serious disease is treated worldwide.
A heartfelt thank you to everyone who has been part of this journey.
And yes — we did it!”
Title: Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
Authors: Josef Kroupa, Martin Radvan, Jan Mrozek, Martin Sluka, Stepan Jirous, Ota Hlinomaz, Milan Pliva, Jan Pudil, Hana Voberkova, Karolina Bartoskova, Martin Poloczek, Martin Kamenik, Michal Brabec, Eva Lichnerova, Martin Hutyra, Ivo Bernat, Martin Novak, Johana Horakova, Lucie Jelinkova, Tomas Knize, Petr Tousek, Cyril Stechovsky, Filip Varhanik, Zdenek Coufal, Jiri Jarkovsky, Viktor Kocka
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs